Highlights:

• Danaher to Acquire Masimo for $9.9B — Danaher Corp. agreed to buy medical technology firm Masimo Corp. in an all-cash transaction. Bloomberg

• Salish Matter Heads to Netflix — YouTube influencer and Sephora success story Salish Matter is expanding to streaming after drawing 87,000 fans to a mall event. Bloomberg

• General Mills Cuts FY2026 Sales Outlook — General Mills Inc. lowered its fiscal 2026 sales guidance citing a more challenging consumer environment. Bloomberg

• South Africa's Film Industry in Crisis — South Africa's film sector faces collapse after the government withheld financial support for two years, leaving thousands of workers without employment. Bloomberg

• Andreessen Horowitz Backs Kavak in $300M Round — Mexico-based used car dealer Kavak raised $300 million in an equity round led by Andreessen Horowitz. Bloomberg

• Genuine Parts to Split Into Two Companies — Genuine Parts Co. will separate its automotive and industrial business lines into two publicly traded entities. Bloomberg

• Warner Bros. Reopens Paramount Talks — Warner Bros Discovery agreed to reopen negotiations with Paramount Skydance after the suitor raised its bid and improved other offer terms. Bloomberg

• Vitamin K Shot Caught in Vaccine Backlash — Growing parental resistance to injections is affecting uptake of vitamin K shots for newborns, despite the treatment being unrelated to vaccines. Bloomberg

• UK Youth Unemployment Hits Decade High — Rising employment costs have driven youth unemployment in Britain to its highest level in ten years. Bloomberg

• Mexico's Auto Sector Hit by Fuel-Smuggling Crackdown — Tighter government controls on fuel smuggling and tax evasion have created lubricant and grease shortages at Mexican auto plants. Bloomberg

• UAE Fertilizer Firm Eyes European Expansion — Fertiglobe Plc sees growth opportunities in Europe as EU curbs on Russian supply reshape the nitrogen fertilizer market. Bloomberg

• Sanofi Drug Shows Promise for Bowel Disease — Sanofi's experimental medicine, developed with Teva Pharmaceuticals, demonstrated efficacy in patients with inflammatory bowel disease. Bloomberg